Is citicoline recommended as a routine supplement for healthy individuals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Citicoline is NOT Recommended as a Routine Supplement for Healthy Individuals

Based on the highest quality evidence, citicoline should not be recommended as a routine supplement for healthy individuals, as there is insufficient evidence to support its use for general health benefits, cognitive enhancement, or disease prevention in this population.

Evidence from Stroke Guidelines (Most Relevant Context)

The American Heart Association/American Stroke Association guidelines provide the clearest guidance on citicoline's clinical utility:

  • The International Citicoline Trial on Acute Stroke (ICTUS), the largest and most definitive trial, enrolled 2,298 patients and was stopped prematurely in 2011 due to futility, showing no difference in 90-day outcomes (OR 1.03; 95% CI 0.86-1.25; P=0.364) 1.

  • Multiple earlier stroke trials failed to demonstrate treatment efficacy on their primary predetermined endpoints 1, 2, 1, 2, 3.

  • While a post-hoc meta-analysis suggested potential benefit in select stroke patients, this exploratory analysis came from a highly selected subgroup, and none of the individual trials could demonstrate benefit 2.

  • Current AHA/ASA guidelines conclude that no neuroprotective agent, including citicoline, can be recommended for treatment 2.

Evidence in Healthy Populations

Regulatory Assessment

  • The European Food Safety Authority (EFSA) concluded in 2024 that a cause-and-effect relationship has NOT been established between citicoline consumption and improvement, maintenance, or reduced loss of memory in middle-aged or elderly adults 4.

  • The EFSA panel found that only one of three pertinent studies showed benefit (episodic memory at 500 mg/day for 12 weeks), while another study using 1 g/day for 3 months showed no effect 4.

  • No convincing evidence of a plausible mechanism by which citicoline could exert effects on memory beyond endogenous synthesis was provided 4.

Clinical Trial Data in Healthy Adults

The limited positive evidence comes from small studies with methodological concerns:

  • One randomized trial (n=100) in healthy older adults with age-associated memory impairment showed improved episodic memory with 500 mg/day for 12 weeks 5.

  • A small study (n=75) in adolescent males showed improved attention and psychomotor speed after 28 days 6.

  • A very small study (n=10) showed EEG changes suggesting improved attention 7.

However, these small positive studies are insufficient to overcome the negative findings from the large ICTUS trial and the lack of regulatory approval for health claims 4.

General Supplement Guidance

The U.S. Preventive Services Task Force provides relevant context for supplement recommendations:

  • The USPSTF concludes there is insufficient evidence to recommend for or against most vitamin and supplement use for disease prevention in healthy adults 8.

  • Patients should be reminded that taking supplements does not replace the need for a healthy diet 8.

  • The American Diabetes Association similarly states there is no clear evidence of benefit from vitamin or mineral supplementation in people without underlying deficiencies 9, 10.

Clinical Bottom Line

For healthy individuals seeking cognitive enhancement or general health benefits, citicoline supplementation cannot be recommended based on current evidence. The following approach is appropriate:

  • Do not recommend citicoline as a routine supplement for healthy individuals 4.

  • Emphasize evidence-based interventions for cognitive health: regular physical activity, healthy diet, smoking cessation, blood pressure control, and management of cardiovascular risk factors 11.

  • If patients choose to use citicoline despite lack of evidence, inform them that safety appears acceptable in short-term studies, but efficacy for their intended use is not established 4, 5.

  • The only potential exception might be older adults with documented age-associated memory impairment who understand the limited and conflicting evidence, though even this cannot be strongly recommended given the EFSA's negative conclusion 4, 5.

Note: The FDA drug label references 12 appear to be for cimetidine (an H2-blocker), not citicoline, and are not relevant to this question.

References

Research

Improvements in quantitative EEG following consumption of a natural citicoline-enhanced beverage.

International journal of food sciences and nutrition, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.